ES467349A1 - Procedimiento para la obtencion de derivados de difenileter. - Google Patents

Procedimiento para la obtencion de derivados de difenileter.

Info

Publication number
ES467349A1
ES467349A1 ES467349A ES467349A ES467349A1 ES 467349 A1 ES467349 A1 ES 467349A1 ES 467349 A ES467349 A ES 467349A ES 467349 A ES467349 A ES 467349A ES 467349 A1 ES467349 A1 ES 467349A1
Authority
ES
Spain
Prior art keywords
preparing same
chlorophenoxy
phenyl
diphenylether
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES467349A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES467349A1 publication Critical patent/ES467349A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/257Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/18Preparation of carboxylic acid esters by conversion of a group containing nitrogen into an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/317Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C67/327Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by elimination of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/63Halogen-containing esters of saturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • C07C69/736Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a nuevos derivados de difenil-éter de fórmula general I **(Fórmula)** donde R1 significa F, Cl, Br o CF3, Y significa COOH, COOR2, CH2OH o CH2OAc, R2 significa alquilo o arilo, en cada caso con hasta 8 átomos de carbono y Ac significa acilo con 1-8 átomos de carbono, así como sus sales fisiológicamente compatibles. Estos compuestos, con buena compatibilidad, poseen propiedades farmacológicas especialmente valiosas. En especial se presentan efectos inhibidores de la agregación de trombocitos, lo que se puede demostrar, por ejemplo, con ayuda del ensayo de agregación de plaquitas.
ES467349A 1977-03-03 1978-02-27 Procedimiento para la obtencion de derivados de difenileter. Expired ES467349A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772709268 DE2709268A1 (de) 1977-03-03 1977-03-03 Diphenylaetherderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen enthaltend diese verbindungen

Publications (1)

Publication Number Publication Date
ES467349A1 true ES467349A1 (es) 1979-07-01

Family

ID=6002710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES467349A Expired ES467349A1 (es) 1977-03-03 1978-02-27 Procedimiento para la obtencion de derivados de difenileter.

Country Status (11)

Country Link
JP (1) JPS53111025A (es)
AU (1) AU3381578A (es)
BE (1) BE864487A (es)
DE (1) DE2709268A1 (es)
ES (1) ES467349A1 (es)
FR (1) FR2424899A1 (es)
IL (1) IL54147A0 (es)
IT (1) IT1113702B (es)
NL (1) NL7802335A (es)
SE (1) SE7802373L (es)
ZA (1) ZA781230B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881868B2 (en) * 2000-07-03 2005-04-19 Speedel Pharma Ag Process for the preparation of (R)-2-alkyl-3-phenyl-1-propanols

Also Published As

Publication number Publication date
IT1113702B (it) 1986-01-20
IT7947985A0 (it) 1979-02-13
IL54147A0 (en) 1978-04-30
JPS53111025A (en) 1978-09-28
NL7802335A (nl) 1978-09-05
BE864487A (fr) 1978-09-04
DE2709268A1 (de) 1978-09-07
ZA781230B (en) 1979-02-28
AU3381578A (en) 1979-09-06
FR2424899A1 (fr) 1979-11-30
SE7802373L (sv) 1978-09-04

Similar Documents

Publication Publication Date Title
SE7710873L (sv) Nya 1h-pyrazolo(3,4-b)pyridiner
ES447150A1 (es) Un procedimiento para la preparacion de un compuesto de pi- perazinilpipazina.
ES467349A1 (es) Procedimiento para la obtencion de derivados de difenileter.
EP0242070A3 (en) Phenyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides
SE7408255L (es)
ES424179A1 (es) Procedimiento para la obtencion de derivados del acido feno-xiacetico.
ES385627A2 (es) Procedimiento para la preparacion de derivados de morfoli- na.
ES421068A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES425216A1 (es) Procedimiento para la preparacion de nuevas triazolo - 1,5 - benzodiazepinas sustituidas.
ES389360A1 (es) Procedimiento para la preparacion de acidos ariloxi- o bienariltioalcanicos.
ES385634A1 (es) Procedimiento para la preparacion de n - cicloalcohil - a- ril - amino - imidazolinas-(2) sustituidas.
GB1399470A (en) Derivatives of pyrazolopyridine ketones
SE8002538L (sv) Anordning for att motverka katodstromokningen som under uppvermningsperioden uppstar i ett vandringsvagror till foljd av endring av galler-katodavstandet
Ross et al. Equilibria of the Boric Acid--Mannitol Complexes
GB1127993A (en) Process for the production of piperazine derivatives
ES391801A1 (es) Un procedimiento para la preparacion de derivados de imida-zolio.
ES446193A1 (es) Un metodo de preparar nuevos compuestos de oxima-eter.
ES418271A1 (es) Procedimiento para la preparacion de nuevos 2-carboxi-4-oxo-4h, 10h-(2)-benzopirano-(4,3-g)-(1)-benzopiranos.
JPS5412348A (en) Cyclopropane carboxylic acid esters, their preparation, and insecticides and acaricides comprising them as active constituents
SU517590A1 (ru) Способ получени 1,2,3,4-тетрагидро-5азациннолинов
ES401333A2 (es) Un procedimiento para preparar nuevas quinoxalina-1,4 - dioxidos, 2 - heterociclico sustituidas.
JPS5227757A (en) Preparation of 6-aminomethylnaphthalene derivatives
GB1199862A (en) A Process for the Manufacture of Dihydro-Benzdiaz[1,4]Epines
GB1389070A (en) Boron-containing prostaglandin intermediates and their preparation
ES390646A1 (es) Procedimiento para la preparacion de ramnopiranosidos.